Search - tctmd.com

Displaying 361 - 380 of 575

Sort: Relevancy | Date

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

News Features

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

Shelley Wood

April 02, 2020

News Conference News ACC 2020

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Michael O'Riordan

March 30, 2020

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

Shelley Wood

March 30, 2020

News Conference News ACC 2020

Colchicine Cost-effective in Canada, and Even in the US: COLCOT

Caitlin E. Cox

March 28, 2020

News Daily News

Who Should Head to the Cath Lab in the COVID-19 Pandemic?

Michael O'Riordan

March 26, 2020

News Daily News

Cardiac Considerations Amid COVID-19: Shared Stories May Save Lives

L.A. McKeown

March 25, 2020

News Daily News

Missed Opportunities: Many HF Patients Not Tested for CAD

L.A. McKeown

March 20, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Daily News

Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease

Shelley Wood

February 27, 2020

News Daily News

Acute MI Symptom Clustering Differs in Men and Women: VIRGO

Michael O'Riordan

February 21, 2020

News Daily News

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

Shelley Wood

February 19, 2020

News Daily News

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Shelley Wood

February 14, 2020

News Daily News

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Shelley Wood

January 20, 2020

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

Shelley Wood

January 14, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2019

Shelley Wood

December 31, 2019

News Daily News

FDA Approves Two Generic Versions of Apixaban

Todd Neale

December 23, 2019

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

Advertisement

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

Colchicine Cost-effective in Canada, and Even in the US: COLCOT

Who Should Head to the Cath Lab in the COVID-19 Pandemic?

Cardiac Considerations Amid COVID-19: Shared Stories May Save Lives

Missed Opportunities: Many HF Patients Not Tested for CAD

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease

Acute MI Symptom Clustering Differs in Men and Women: VIRGO

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

The Cancer Patient Needing PCI Poses Conundrums for Care

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

TCTMD’s Top 10 Most Popular Stories for December 2019

FDA Approves Two Generic Versions of Apixaban

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content